Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 30.11.2013 | EN | Official Journal of the European Union | C 352/14 |

---

Judgment of the General Court of 16 October 2013 — Mundipharma v OHIM — AFT Pharmaceuticals (Maxigesic)

(Case T-328/12)[(1)](#ntr1-C_2013352EN.01001402-E0001)

(Community trade mark - Opposition proceedings - Application for Community word mark Maxigesic - Earlier Community word mark OXYGESIC - Article 8(1)(b) of Regulation (EC) No 207/2009)

2013/C 352/26

Language of the case: German

Parties

Applicant: Mundipharma GmbH (Limburg an der Lahn, Germany) (represented by: F. Nielsen, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: D. Walicka, acting as Agent)

Other party to the proceedings before the Board of Appeal of OHIM, intervener before the General Court: AFT Pharmaceuticals Ltd (Takapuna, New Zealand) (represented by: M. Nentwig, L. Kouker and G.M. Becker, lawyers)

Re:

Action brought against the decision of the Fourth Board of Appeal of OHIM of 23 May 2012 (Case R 1788/2010-4), concerning opposition proceedings between Mundipharma GmbH and AFT Pharmaceuticals Ltd

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Mundipharma GmbH to pay the costs. |

---

[Top](#document1)